Comparing Brief Relaxation Period to Virtual Reality Period in Reducing Dental Anxiety Prior to Root Canal Treatment

May 9, 2023 updated by: Stuart Schrader, Indiana University

Comparing Brief Relaxation Period to Virtual Reality Period in Reducing Dental Anxiety Prior to Root Canal Treatment; a Randomized Control Trial

The goal of this study is to evaluate non-drug approaches to reducing dental anxiety prior to non-surgical root canal treatment. This will be done by comparing two relaxation methods which will be performed immediately prior to scheduled, clinical non-surgical root canal treatment. Measures of anxiety will be evaluated prior to, and after, the relaxation intervention, as well as after the non-surgical root canal treatment is completed. Participation in the study is completed in a single study visit.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Indiana University, School of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • requires non-surgical root canal treatment
  • is able to independently provide informed consent for root canal treatment
  • proficient in English

Exclusion Criteria:

  • history of vertigo or severe motion sickness
  • history of severe psychiatric disease
  • history of seizures, concussions, or severe neurological conditions
  • visual or hearing impairments
  • cardiac pacemaker or defibrillator
  • will require nitrous oxide sedation, nor pharmacologic anxiolytics or sedatives for dental treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Auditory Alone Brief Relaxation
Participants randomized to this arm will receive earphones to listen to a guided brief relaxation recording, focusing on breathing and a body scan, prior to their dental procedure.
Participants randomized to this arm will receive earphones to listen to an 8 minute guided brief relaxation recording, focusing on breathing and a body scan. Participants will listen to the recording prior to their dental procedure.
Other Names:
  • ABR
Experimental: Relaxation Virtual Reality
Participants will receive virtual reality goggles and choose a scene of their liking to experience, prior to their dental procedure.
Participants randomized to this arm will receive will receive virtual reality goggles and choose a scene of their liking to experience. Participants will choose from 11 different themed environments (such as savannah, beach, meadow, or space), and will experience the chosen virtual reality environment for 8 minutes. Participants will complete the virtual reality intervention prior to their dental procedure.
Other Names:
  • RVR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change from baseline in State-Trait Anxiety Indicator (STAI) Score at the end of the study visit
Time Frame: From enrollment to the end of the dental visit, approximately 90 minutes
STAI is a 40 item questionnaire which measures subjective self-reported feelings of dental anxiety. Responses for each item include four possible responses that range from "very much" to "not at all" and which correlate to a numerical value. A score of 45-80 indicate "high anxiety": 38-44 indicate "moderate anxiety": 20-37 indicate low or no anxiety. During the single study visit, participants will complete the STAI twice: at enrollment (prior to undergoing the randomly assigned relaxation intervention) and again at the end of the visit.
From enrollment to the end of the dental visit, approximately 90 minutes
Mean Change from baseline in anxiety as rated on a Visual Analog Score (VAS) at the end of the relaxation intervention
Time Frame: From enrollment to the end of the relaxation intervention, approximately 10 minutes
The VAS will be a single question in which the participant is asked to assign and report a numerical value to the amount of anxiety one is feeling in the moment. It consists of a 10 point scale, with one symbolizing no anxiety and 10 symbolizing unbearable anxiety. During the single study visit, participants will complete the VAS three times: at enrollment (prior to the assigned relaxation intervention), at the end of the relaxation intervention, and at the end of the study visit.
From enrollment to the end of the relaxation intervention, approximately 10 minutes
Mean Change from baseline in anxiety as rated on a Visual Analog Score (VAS) at the end of the study visit
Time Frame: From enrollment to the end of the dental visit, approximately 90 minutes
The VAS will be a single question in which the participant is asked to assign and report a numerical value to the amount of anxiety one is feeling in the moment. It consists of a 10 point scale, with one symbolizing no anxiety and 10 symbolizing unbearable anxiety. During the single study visit, participants will complete the VAS three times: at enrollment (prior to the assigned relaxation intervention), at the end of the relaxation intervention, and at the end of the study visit.
From enrollment to the end of the dental visit, approximately 90 minutes
Mean Change from baseline in blood pressure (BP) at the end of the relaxation intervention
Time Frame: From enrollment to the end of the relaxation intervention, approximately 10 minutes
BP will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the visit.
From enrollment to the end of the relaxation intervention, approximately 10 minutes
Mean Change from baseline in blood pressure (BP) at the end of the study visit
Time Frame: From enrollment to the end of the dental visit, approximately 90 minutes
BP will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the visit.
From enrollment to the end of the dental visit, approximately 90 minutes
Mean Change from baseline in heart rate (HR) to the end of the relaxation intervention
Time Frame: From enrollment to the end of the relaxation intervention, approximately 10 minutes
HR will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the study visit.
From enrollment to the end of the relaxation intervention, approximately 10 minutes
Mean Change from baseline in heart rate (HR) at the end of the study visit
Time Frame: From enrollment to the end of the dental visit, approximately 90 minutes
HR will be measured three times during the single study visit: at enrollment (prior to the assigned relaxation intervention), at the end of the assigned relaxation intervention, and at the end of the study visit.
From enrollment to the end of the dental visit, approximately 90 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2023

Primary Completion (Actual)

April 3, 2023

Study Completion (Actual)

April 3, 2023

Study Registration Dates

First Submitted

January 9, 2023

First Submitted That Met QC Criteria

January 31, 2023

First Posted (Actual)

February 9, 2023

Study Record Updates

Last Update Posted (Estimate)

May 11, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB # 17053

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Anxiety

Clinical Trials on Auditory Alone

Subscribe